Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Satlin MJ, van Duin D, Tamma PD, Lodise TP, Van Tyne D, Rodvold KA, Rouphael N, Evans SR, Fowler VG, Hamasaki T, Patel R, Komarow L, Baum K, Souli M, Schwager N, Bonomo RA, Doi Y; Antibacterial Resistance Leadership Group. Satlin MJ, et al. Among authors: souli m. Clin Infect Dis. 2023 Oct 16;77(Suppl 4):S305-S313. doi: 10.1093/cid/ciad547. Clin Infect Dis. 2023. PMID: 37843118 Free PMC article.
Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group.
Cross HR, Greenwood-Quaintance KE, Souli M, Komarow L, Geres HS, Hamasaki T, Chambers HF, Fowler VG, Evans SR, Patel R; Antibacterial Resistance Leadership Group. Cross HR, et al. Among authors: souli m. Clin Infect Dis. 2023 Oct 16;77(Suppl 4):S288-S294. doi: 10.1093/cid/ciad529. Clin Infect Dis. 2023. PMID: 37843120 Free PMC article.
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial.
Tamma PD, Souli M, Billard M, Campbell J, Conrad D, Ellison DW, Evans B, Evans SR, Greenwood-Quaintance KE, Filippov AA, Geres HS, Hamasaki T, Komarow L, Nikolich MP, Lodise TP, Nayak SU, Norice-Tra C, Patel R, Pride D, Russell J, Van Tyne D, Chambers HF, FowlerJr VG, Schooley RT; Antibacterial Resistance Leadership Group. Tamma PD, et al. Among authors: souli m. Trials. 2022 Dec 28;23(1):1057. doi: 10.1186/s13063-022-07047-5. Trials. 2022. PMID: 36578069 Free PMC article.
Black and White Patients With Staphylococcus aureus Bacteremia Have Similar Outcomes but Different Risk Factors.
Ruffin F, Dagher M, Park LP, Wanda L, Hill-Rorie J, Mohnasky M, Marshall J, Souli M, Lantos P, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Muiruri C, Broadnax B, Fowler VG. Ruffin F, et al. Among authors: souli m. Clin Infect Dis. 2023 Apr 3;76(7):1260-1265. doi: 10.1093/cid/ciac893. Clin Infect Dis. 2023. PMID: 36373405 Free PMC article.
Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial.
Banerjee R, Giri A, Komarow L, Souli M, Doernberg SB, Patel R; Antibacterial Resistance Leadership Group. Banerjee R, et al. Among authors: souli m. Microbiol Spectr. 2024 Dec 16:e0178924. doi: 10.1128/spectrum.01789-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 39679788 Free article.
111 results